Melanoma is the skin cancer with the dramatic flair of a movie villain: it may start as a suspicious mole, but if ignored, it can travel. When melanoma spreads beyond the original skin site to lymph nodes, organs, bones, or the brain, doctors call it metastatic melanoma, also known as stage IV melanoma in many cases.
The good news is that metastatic melanoma treatment has changed dramatically. Not long ago, advanced melanoma had limited options. Today, immunotherapy, targeted therapy, cellular therapy, surgery, radiation, and clinical trials give many patients more realistic reasons to hope. This does not make metastatic melanoma “easy”it is still seriousbut it does mean the conversation has shifted from “What now?” to “What is the smartest plan?”
This guide explains metastatic melanoma symptoms, stages, diagnosis, and treatment options in clear American English, with just enough humor to make a tough topic readable. No lab coat required.
What Is Metastatic Melanoma?
Metastatic melanoma is melanoma that has spread from its original location to another part of the body. Melanoma begins in melanocytes, the pigment-producing cells that give skin its color. It most often appears on the skin, but it can also develop in the eye, under nails, or on mucous membranes such as the mouth or genital area.
Melanoma becomes metastatic when cancer cells break away, travel through lymph vessels or the bloodstream, and form tumors elsewhere. Common sites include nearby or distant lymph nodes, lungs, liver, brain, bones, and gastrointestinal tract. In plain English: melanoma can be a traveler, and unlike your aunt’s vacation photos, its travel plans are not welcome.
Early Melanoma Symptoms: The Skin Clues
Many metastatic melanoma stories begin with a mole or spot that changed. The classic warning tool is the ABCDE rule:
- A Asymmetry: One half does not match the other.
- B Border: Edges are irregular, blurred, jagged, or notched.
- C Color: The spot has multiple colors, such as brown, black, red, blue, gray, or white.
- D Diameter: The spot is larger than about 6 millimeters, although smaller melanomas can occur.
- E Evolving: The mole changes in size, shape, color, elevation, or symptoms.
Other red flags include itching, bleeding, crusting, tenderness, a sore that will not heal, or a new dark streak under a nail. Some melanomas do not follow the ABCDE checklist neatly, because cancer apparently did not read the brochure. That is why any changing or unusual skin lesion deserves medical attention.
Metastatic Melanoma Symptoms: When Melanoma Spreads
Symptoms of metastatic melanoma depend on where the cancer has spread. Some people have no obvious symptoms at first, and metastases are found through scans or follow-up testing. Others notice body-wide changes or organ-specific warning signs.
General Symptoms
- Unexplained weight loss
- Persistent fatigue that does not improve with rest
- Loss of appetite
- Swollen lymph nodes
- Ongoing pain without a clear injury
- Night sweats or unexplained fevers
Symptoms If Melanoma Spreads to the Lungs
Lung metastases may cause coughing, shortness of breath, chest discomfort, wheezing, or coughing up blood. Sometimes small lung metastases produce no symptoms and are detected only on imaging.
Symptoms If Melanoma Spreads to the Liver
Liver involvement may cause belly pain or swelling, nausea, appetite loss, yellowing of the skin or eyes, dark urine, or abnormal liver blood tests.
Symptoms If Melanoma Spreads to the Brain
Brain metastases can cause headaches, vision changes, seizures, confusion, weakness, balance problems, personality changes, or speech difficulties. New neurological symptoms should be treated as urgent.
Symptoms If Melanoma Spreads to Bones
Bone metastases may cause deep bone pain, back pain, fractures, weakness, or high calcium levels. Bone pain that is persistent, worsening, or unrelated to an injury should not be brushed off as “just getting older.” Aging already takes enough blame.
Melanoma Stages Explained
Melanoma staging helps doctors estimate how far the cancer has spread and choose treatment. The main system looks at tumor thickness, ulceration, lymph node involvement, and distant spread.
Stage 0: Melanoma in Situ
Stage 0 means melanoma cells are only in the top layer of the skin. This is the earliest stage and is usually treated with surgery.
Stage I and Stage II: Localized Melanoma
Stage I and II melanomas are still localized to the skin but vary in thickness and risk features. Surgery is the main treatment. Some higher-risk stage II melanomas may be considered for additional therapy after surgery.
Stage III: Regional Spread
Stage III melanoma has spread to nearby lymph nodes, lymph vessels, or nearby skin areas. It may still be removable with surgery, but systemic treatments such as immunotherapy or targeted therapy may be recommended before or after surgery.
Stage IV: Metastatic Melanoma
Stage IV melanoma means the cancer has spread to distant lymph nodes, organs, bones, brain, or other distant tissues. This is the stage most people mean when they say metastatic melanoma. Treatment usually focuses on systemic therapy, meaning medicine that travels through the body.
How Doctors Diagnose Metastatic Melanoma
Diagnosis usually begins with a skin exam and biopsy of a suspicious lesion. If melanoma is confirmed, additional tests may be used to determine whether it has spread.
- Skin biopsy: Removes suspicious tissue for laboratory analysis.
- Sentinel lymph node biopsy: Checks the first lymph node or nodes where melanoma is likely to spread.
- CT, PET, or MRI scans: Look for spread to organs, bones, lymph nodes, or brain.
- Blood tests: May check overall health, organ function, and sometimes lactate dehydrogenase, or LDH, which can help with prognosis.
- Molecular testing: Looks for mutations such as BRAF V600, which can guide targeted therapy choices.
Molecular testing is especially important in advanced melanoma. If the tumor has a BRAF mutation, targeted medications may be an option. If it does not, immunotherapy may still be used. Treatment planning today is less one-size-fits-all and more “let’s interrogate the tumor like it owes us money.”
Metastatic Melanoma Treatment Options
Treatment depends on the stage, mutation status, symptoms, tumor location, speed of growth, previous treatments, overall health, and patient preferences. A melanoma care team may include a medical oncologist, dermatologist, surgeon, radiation oncologist, radiologist, pathologist, oncology nurse, and supportive care specialists.
1. Immunotherapy
Immunotherapy helps the immune system recognize and attack melanoma cells. The most common drugs are immune checkpoint inhibitors, including PD-1 inhibitors such as pembrolizumab and nivolumab, CTLA-4 inhibitors such as ipilimumab, and LAG-3 combinations such as nivolumab plus relatlimab.
Immunotherapy can produce durable responses in some patients, meaning the cancer stays controlled for a long time. However, it can also cause immune-related side effects because an activated immune system may attack normal tissues. Possible problems include skin rash, diarrhea, colitis, thyroid changes, liver inflammation, lung inflammation, joint pain, and hormone gland issues.
2. Targeted Therapy for BRAF-Mutated Melanoma
About a portion of melanomas have changes in the BRAF gene, especially BRAF V600 mutations. For these cancers, doctors may use combinations of BRAF and MEK inhibitors. Examples include dabrafenib plus trametinib, vemurafenib plus cobimetinib, or encorafenib plus binimetinib.
Targeted therapy can work quickly, which may be useful when melanoma is growing fast or causing serious symptoms. The trade-off is that responses may be less durable for some patients than immunotherapy. Side effects can include fever, fatigue, rash, joint pain, diarrhea, sun sensitivity, heart effects, eye problems, or liver test changes.
3. Tumor-Infiltrating Lymphocyte Therapy
Tumor-infiltrating lymphocyte therapy, often called TIL therapy, uses immune cells taken from a patient’s own tumor. These cells are grown in large numbers in a lab and returned to the body to attack cancer. Lifileucel is an FDA-approved cellular therapy for certain adults with unresectable or metastatic melanoma after prior treatment with a PD-1 blocker and, when appropriate, BRAF-targeted therapy.
TIL therapy is not a casual “swing by after lunch” treatment. It can involve surgery to remove tumor tissue, cell manufacturing time, chemotherapy preparation, cell infusion, and close monitoring. For selected patients, especially after other treatments stop working, it may offer another path.
4. Surgery
Surgery may remove the original melanoma, involved lymph nodes, or selected metastatic tumors. In stage IV disease, surgery is not always possible, but it can help if there are limited metastases, if a tumor is causing symptoms, or if removing a spot improves control alongside systemic therapy.
5. Radiation Therapy
Radiation therapy may be used to treat brain metastases, bone pain, spinal cord compression risk, or other specific areas causing symptoms. Stereotactic radiosurgery is sometimes used for small brain metastases with focused precision.
6. Clinical Trials
Clinical trials test new combinations, new immune approaches, cancer vaccines, cellular therapies, and strategies for treatment-resistant melanoma. A clinical trial is not a last-ditch science experiment in a basement. It is a structured medical study with rules, monitoring, and eligibility criteria. For metastatic melanoma, asking about trials is often smart.
Choosing Treatment: What Doctors Consider
No single treatment is best for every patient. Doctors weigh several questions:
- Is the melanoma BRAF-positive or BRAF-negative?
- How fast is the disease progressing?
- Are there symptoms that require rapid control?
- Has melanoma spread to the brain, liver, bone, or lungs?
- Has the patient already received immunotherapy or targeted therapy?
- Does the patient have autoimmune disease or other conditions that affect treatment safety?
- What are the patient’s goals, work life, family needs, and tolerance for risk?
For many patients, immunotherapy is a preferred first approach because responses can last. For BRAF-mutated melanoma with aggressive symptoms, targeted therapy may be used because it can shrink tumors faster. Sometimes treatments are sequenced over time. The strategy matters almost as much as the medication.
Living With Metastatic Melanoma
Living with metastatic melanoma is not only about scans and prescriptions. It is also about energy, anxiety, skin checks, side effects, family conversations, insurance paperwork, nutrition, sleep, and the emotional gymnastics of waiting for test results.
Practical habits can help:
- Keep a symptom journal, including pain, appetite, fatigue, bowel changes, headaches, and mood.
- Report new symptoms early, especially breathing problems, severe diarrhea, vision changes, confusion, or neurological symptoms.
- Bring a written question list to appointments.
- Ask whether molecular testing has been done.
- Discuss side effects before starting treatment so you know what is normal and what is urgent.
- Protect skin from UV exposure with sunscreen, shade, hats, and protective clothing.
- Use support services such as counseling, oncology social work, nutrition support, and patient groups.
Prevention and Follow-Up Still Matter
Even after a melanoma diagnosis, sun protection matters. UV exposure can raise the risk of additional skin cancers. Regular dermatology exams, self-skin checks, and follow-up imaging or blood work may be part of long-term care. Family members may also benefit from learning melanoma warning signs, especially if there is a strong family history.
Think of skin checks like checking your car’s dashboard lights. You do not panic every time a light comes on, but you also do not cover it with tape and hope for the best.
Experiences Related to Metastatic Melanoma: What Patients Often Learn the Hard Way
Every metastatic melanoma experience is personal, but certain lessons come up again and again in clinics, support groups, and caregiver conversations. The first is that many people wish they had taken a changing mole seriously sooner. A spot that bleeds, itches, darkens, grows, or looks different from the “neighborhood” of other moles is not being quirky. It is asking for attention. The “ugly duckling” sign matters: if one mole looks noticeably different from the rest, it deserves a professional look.
Another common experience is scan anxiety. Patients may feel fairly calm between appointments and then suddenly become professional overthinkers the week before imaging. This is normal. Waiting for CT, PET, or MRI results can make time move like a sleepy snail. Many patients find it helpful to schedule something ordinary but comforting after scan day: a favorite meal, a walk, a movie, or time with someone who does not say, “Don’t worry,” every seven seconds. Good intentions are lovely; repetitive advice is less lovely.
Side effects are another reality. Immunotherapy can feel surprisingly easy for one person and very challenging for another. Some patients continue working and exercising. Others deal with fatigue, rash, diarrhea, hormone changes, or inflammation that requires steroids or treatment pauses. The key lesson is not to “tough it out” silently. With metastatic melanoma treatment, early reporting can prevent side effects from becoming dangerous. Diarrhea, shortness of breath, yellowing skin, severe headache, vision changes, or confusion should be reported quickly.
Caregivers also learn that help needs to be specific. “Let me know if you need anything” is kind, but it puts homework on the patient. Better offers sound like: “I can drive you Tuesday,” “I made soup,” “I can sit with you during infusion,” or “I can handle the pharmacy pickup.” Cancer already comes with paperwork, phone calls, and emotional static. Practical help cuts through the noise.
Many patients also discover the importance of second opinions. Getting another melanoma specialist to review the case does not mean the first doctor failed. It means metastatic melanoma is complex, treatment options are evolving, and major decisions deserve expert eyes. This is especially true when choosing between immunotherapy, targeted therapy, TIL therapy, radiation for brain metastases, surgery, or a clinical trial.
Finally, people often learn that hope and realism can sit at the same table. Metastatic melanoma is serious. It can be unpredictable. But modern treatment has created outcomes that were once rare. Patients do not need forced positivity or gloomy statistics thrown like wet blankets. They need clear information, skilled care, honest conversations, and a plan that can adapt. In other words: science, support, and snacks. Never underestimate snacks.
Conclusion
Metastatic melanoma is advanced skin cancer that has spread beyond its original site, often to lymph nodes, lungs, liver, brain, bones, or other organs. Symptoms may include changing moles, swollen lymph nodes, fatigue, weight loss, pain, cough, headaches, seizures, or organ-specific problems. Staging helps guide treatment, and stage IV melanoma usually requires systemic therapy.
The treatment landscape has improved greatly. Immunotherapy, targeted therapy, TIL therapy, surgery, radiation, and clinical trials may all play a role. The best plan depends on mutation status, disease location, symptoms, previous treatment, and personal goals. Anyone facing metastatic melanoma should work with an experienced oncology team and speak up early about new symptoms or side effects.
